Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.2350
-0.0050 (-2.08%)
At close: Mar 31, 2026
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 120.57 million as of March 31, 2026. Its market cap has increased by 331.65% in one year.
Market Cap
120.57M
Enterprise Value
91.80M
Revenue
5.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
Market Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 120.57M, an increase of 249.52%. That is a compound annual growth rate of 10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 120.57M | 56.67% |
| Dec 31, 2025 | 76.96M | 122.90% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | - |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 196.70M |
| Starpharma Holdings | 193.26M |
| Dimerix | 177.12M |
| Recce Pharmaceuticals | 133.02M |
| Actinogen Medical | 118.52M |
| Paradigm Biopharmaceuticals | 115.68M |
| Island Pharmaceuticals | 109.32M |
| Botanix Pharmaceuticals | 88.72M |